Page 137 - MemoriaESP-Eng

www.ciberesp.es

• Health care and outcomes assessment in cancer patients

- Survival and patterns of care in cancer and variability in clinical practice (diagnostic

methods, stage, treatment, tumor markers, second primary cancers, recurrences):
differences between countries and geographical areas (EUROCARE, CONCORD and

EMPARO-CU projects).

- Surveillance and control of rare tumors in Spain and Europe (EUROCARE project).

• Mapping of the European funding in cancer research activities: bibliometric and
health impact assessment (MAPPING_NCD project).

• puig-ViVes M, sáncHez MJ, sáncHez-cAntAleJo J, torrellA-rAMos A, MArtos c, ArDAnAz e.
Most relevant
Distribution and prognosis of molecular breast cancer subtypes defined by immuno-
scientific histochemical biomarkers in a Spanish population-based study.Gynecol Oncol. 2013

articles
Sep;130(3):609-14.

• MolinA-Montes e, pollán M, pAyer t, MolinA e, DáVilA-AriAs c, sáncHez MJ. Risk of se-
cond primary cancer among women with breast cancer: a population-based study

in Granada (Spain).Gynecol Oncol. 2013 Aug;130(2):340-5.

• zAMorA-ros r, JiMénez c, cleries r, AguDo A, sáncHez MJ, sáncHez-cAntAleJo e. Dietary á
flavonoid and lignan intake and mortality in a Spanish cohort.Epidemiology. 2013

Sep;24(5):726-33.

• steFFen A, sørensen ti, Knüppel s, trAVier n, sáncHez MJ, HuertA JM. Development and

validation of a risk score predicting substantial weight gain over 5 years in middle-
aged European men and women.PLoS One. 2013;8(7):e67429.

• JAKszyn p, luJn-bArroso l, AguDo A, bueno-De-MesquitA Hb, MolinA e, sáncHez MJ.

Meat and heme iron intake and esophageal adenocarcinoma in the European
Prospective Investigation into Cancer and Nutrition study.Int J Cancer. 2013 Dec

1;133(11):2744-50.

Highlights
Group 34 of the CIBERESP has received European funding to the project MAPPING_NCD and
to coordinate one of the work packages (WP5) on cancer research activities. At the national

level, a project on lifestyle factors and genetic susceptibility as predictors of cancer risk

has been funded in 2013 by the Spanish Ministry of Economy by means of the AES (ISCIII,
FIS). Our group is currently coordinating and/or participating in other 6 research projects.

Some members of our group were awarded in 2013 for their excellence in research: the
best published article in epidemiology in 2012, given by the Spanish Society of Epidemiolo-

gy (SEE), the best senior communication presented during the SEE congress, and the best

poster presented during the congress of the International Association of Cancer Registries
(IACR).

The scientific production of the group in terms of articles is 83 indexed publications, with 13
20
the majority being produced through collaborative studies with national and international T
research groups (79.% of the articles were published in journals belonging to the first quar- OR
P
tile). The total impact factor (IF) in 2013 is: 382.2. The mean IF per article is: 5.03; 37.3% RE
of the articles belong to the 1st decile.
L
óA
Within the Granada Cancer Registry, the data of cancer incidence in Granada of the period NU
N
1985-2007 has been published in the 5-yearly publication of Cancer Incidence in Five Conti- A
nents, vol X (IARC). Also, data has been provided for the publication International Incidence P /
S
of Childhood Cancer, Vol 3 and for the international projects EUROCARE-5 and CONCORD-2.
RE
E
Our group has been also involved in the creation of the Instituto de Investigacin Biosani- IB
taria de Granada. The PI of our group is the coordinator of the “Cancer” area, which is one C

of the five fields of research leaded by this Institute.
137